Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXW6R0
|
||||
Drug Name |
(S)-1-(1H-indol-4-yloxy)-3-((2S,4R)-4-(6-methoxybenzo[b]thiophen-2-yl)-2-methylpiperidin-1-yl)propan-2-ol
|
||||
Synonyms |
CHEMBL78405
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C26H30N2O3S
|
||||
Canonical SMILES |
COc1ccc2cc(sc2c1)[C@@H]3CCN(C[C@H](O)COc4cccc5[nH]ccc45)[C@@H](C)C3
|
||||
InChI |
InChI=1S/C26H30N2O3S/c1-17-12-19(25-13-18-6-7-21(30-2)14-26(18)32-25)9-11-28(17)15-20(29)16-31-24-5-3-4-23-22(24)8-10-27-23/h3-8,10,13-14,17,19-20,27,29H,9,11-12,15-16H2,1-2H3/t17-,19+,20-/m0/s1
|
||||
InChIKey |
CLBIXESACWOVRD-SXLOBPIMSA-N
|
||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
5HT2 type receptor mediated signaling pathway | |||||
5HT3 type receptor mediated signaling pathway | |||||
5HT4 type receptor mediated signaling pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.